Concepedia

Laurel L. Ballantyne

LL

Statistics

Publications

13

Citations

491

H-Index

13

Active since

2011

Affiliations

Queen's University(Current)

Translational Therapeutics (United States)

University of Pennsylvania

Hospital for Sick Children

University of Toronto

Laurel L. Ballantyne is an author at Queen's University specializing in medicine, oxidative stress, and pharmacology.

ORCID

Top concepts

Publications per year

2011–2019

13

Publications

13

Perivascular adipose tissue–derived extracellular vesicle miR‐221‐3p mediates vascular remodeling

Xinzhi Li, Laurel L. Ballantyne, Ying Yu et al. · The FASEB Journal · 2019 · 137 citations · Full text

A Selective Cysteinyl Leukotriene Receptor 2 Antagonist Blocks Myocardial Ischemia/Reperfusion Injury and Vascular Permeability in Mice

Nathan C. Ni, Yan Dong, Laurel L. Ballantyne et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 61 citations

Heme oxygenase-1 overexpression exacerbates heart failure with aging and pressure overload but is protective against isoproterenol-induced cardiomyopathy in mice

Melissa A. Allwood, Robert Kinobe, Laurel L. Ballantyne et al. · Cardiovascular Pathology · 2014 · 49 citations

, , +10

Inducible Arginase 1 Deficiency in Mice Leads to Hyperargininemia and Altered Amino Acid Metabolism

Yuan Yan Sin, Laurel L. Ballantyne, Kamalika Mukherjee et al. · PLoS ONE · 2013 · 48 citations · Full text

Endogenously Generated Omega‐3 Fatty Acids Attenuate Vascular Inflammation and Neointimal Hyperplasia by Interaction With Free Fatty Acid Receptor 4 in Mice

Xinzhi Li, Laurel L. Ballantyne, Xinghui Che et al. · Journal of the American Heart Association · 2015 · 39 citations · Full text

1–5 of 13